IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 329 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $636,000 | -66.9% | 9,895 | -77.3% | 0.04% | -53.2% |
| Q1 2018 | $1,920,000 | -42.0% | 43,570 | -33.8% | 0.08% | -47.3% |
| Q4 2017 | $3,308,000 | +203.8% | 65,770 | +142.7% | 0.15% | +192.0% |
| Q1 2017 | $1,089,000 | -8.2% | 27,100 | -7.5% | 0.05% | -5.7% |
| Q1 2016 | $1,186,000 | -79.5% | 29,304 | -68.6% | 0.05% | -80.7% |
| Q4 2015 | $5,774,000 | – | 93,239 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |